Cargando…
Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is regarded as one of the most common malignancies and among the leading causes of cancer death among the whole world. The most urgent needs are to find sensitive markers for early diagnosis or monitor postoperative recurrence and to give adequate treatment...
Autores principales: | Zhang, Zhu-qing, Meng, Hua, Wang, Nan, Liang, Li-na, Liu, Li-na, Lu, Shu-ming, Luan, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226970/ https://www.ncbi.nlm.nih.gov/pubmed/24993656 http://dx.doi.org/10.1186/1746-1596-9-135 |
Ejemplares similares
-
Decreased circulating microRNA-21 and microRNA-143 are associated to pulmonary hypertension
por: DÜZGÜN, Zekeriya, et al.
Publicado: (2022) -
MicroRNA-215 as a Diagnostic Marker in Egyptian Patients with Hepatocellular Carcinoma
por: El Mahdy, Hussein Ahmed, et al.
Publicado: (2019) -
MicroRNA-143/-145 in Cardiovascular Diseases
por: Zhao, Wang, et al.
Publicado: (2015) -
MicroRNA-143 Targets Syndecan-1 to Repress Cell Growth in Melanoma
por: Li, Ruiya, et al.
Publicado: (2014) -
Serum MicroRNAs as Biomarkers in Hepatitis C: Preliminary Evidence of a MicroRNA Panel for the Diagnosis of Hepatocellular Carcinoma
por: Weis, Anna, et al.
Publicado: (2019)